Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients: A follow-up study

Bernardo Dell'Osso, Cristina Dobrea, Chiara Arici, Beatrice Benatti, Roberta Ferrucci, Maurizio Vergari, Alberto Priori, A. Carlo Altamura

Research output: Contribution to journalArticle

Abstract

Objectives Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique that has received increasing interest in the area of mood disorders over the last several years. While acute, double-blind, sham-controlled studies have already reported positive findings in terms of efficacy and safety for tDCS, follow-up data are lacking. This need prompted the present follow-up study, which assesses post-acute effects of tDCS (no maintenance stimulation was performed), in the mid-term, in a sample of major depressives. Methods After completing an acute, open trial of tDCS, 23 outpatients with either major depressive disorder or bipolar disorder entered a naturalistic follow-up (T1) with clinical evaluations at one week (T2), 1 month (T3), and 3 months (T4). A quantitative analysis of Hamilton Depression Rating Scale (HAM-D), Montgomery-Asberg Depression Rating Scale (MADRS), and Young Mania Rating Scale (YMRS) total scores, through repeated measures analysis of variance (ANOVA) (T1-T4) and paired t-test for comparing specific time points (T1-T2, T2-T3, and T3-T4), was performed. In addition, a qualitative analysis on the basis of treatment response and remission (HAM-D) was performed. Results Even though a progressive reduction of follow-up completers was observed from T2 to T4 (95.6% at T2, 65.2% at T3, and 47.8% at T4), the antidepressant effects of acute tDCS persisted over 3 months in almost half of the sample. Of note, no post-acute side effects emerged during the follow-up observation. The most frequent causes of drop-out from this study included major modifications in therapeutic regimen (30%) and poor adherence to follow-up visits (17%). Conclusions In this mid-term, open, follow-up study, tDCS showed mixed results. Further controlled studies are urgently needed to assess its effects beyond the acute phase.

Original languageEnglish
Pages (from-to)347-354
Number of pages8
JournalCNS Spectrums
Volume19
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Bipolar Disorder
Depression
Major Depressive Disorder
Mood Disorders
Antidepressive Agents
Transcranial Direct Current Stimulation
Analysis of Variance
Outpatients
Maintenance
Observation
Safety
Therapeutics

Keywords

  • Bipolar disorder
  • follow-up observation
  • major depressive disorder
  • poor response
  • transcranial direct current stimulation (tDCS)

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients : A follow-up study. / Dell'Osso, Bernardo; Dobrea, Cristina; Arici, Chiara; Benatti, Beatrice; Ferrucci, Roberta; Vergari, Maurizio; Priori, Alberto; Altamura, A. Carlo.

In: CNS Spectrums, Vol. 19, No. 4, 2014, p. 347-354.

Research output: Contribution to journalArticle

@article{01c256fd3d2a4edf8622dd83a6194ab2,
title = "Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients: A follow-up study",
abstract = "Objectives Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique that has received increasing interest in the area of mood disorders over the last several years. While acute, double-blind, sham-controlled studies have already reported positive findings in terms of efficacy and safety for tDCS, follow-up data are lacking. This need prompted the present follow-up study, which assesses post-acute effects of tDCS (no maintenance stimulation was performed), in the mid-term, in a sample of major depressives. Methods After completing an acute, open trial of tDCS, 23 outpatients with either major depressive disorder or bipolar disorder entered a naturalistic follow-up (T1) with clinical evaluations at one week (T2), 1 month (T3), and 3 months (T4). A quantitative analysis of Hamilton Depression Rating Scale (HAM-D), Montgomery-Asberg Depression Rating Scale (MADRS), and Young Mania Rating Scale (YMRS) total scores, through repeated measures analysis of variance (ANOVA) (T1-T4) and paired t-test for comparing specific time points (T1-T2, T2-T3, and T3-T4), was performed. In addition, a qualitative analysis on the basis of treatment response and remission (HAM-D) was performed. Results Even though a progressive reduction of follow-up completers was observed from T2 to T4 (95.6{\%} at T2, 65.2{\%} at T3, and 47.8{\%} at T4), the antidepressant effects of acute tDCS persisted over 3 months in almost half of the sample. Of note, no post-acute side effects emerged during the follow-up observation. The most frequent causes of drop-out from this study included major modifications in therapeutic regimen (30{\%}) and poor adherence to follow-up visits (17{\%}). Conclusions In this mid-term, open, follow-up study, tDCS showed mixed results. Further controlled studies are urgently needed to assess its effects beyond the acute phase.",
keywords = "Bipolar disorder, follow-up observation, major depressive disorder, poor response, transcranial direct current stimulation (tDCS)",
author = "Bernardo Dell'Osso and Cristina Dobrea and Chiara Arici and Beatrice Benatti and Roberta Ferrucci and Maurizio Vergari and Alberto Priori and Altamura, {A. Carlo}",
year = "2014",
doi = "10.1017/S1092852913000497",
language = "English",
volume = "19",
pages = "347--354",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "MBL Communications",
number = "4",

}

TY - JOUR

T1 - Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients

T2 - A follow-up study

AU - Dell'Osso, Bernardo

AU - Dobrea, Cristina

AU - Arici, Chiara

AU - Benatti, Beatrice

AU - Ferrucci, Roberta

AU - Vergari, Maurizio

AU - Priori, Alberto

AU - Altamura, A. Carlo

PY - 2014

Y1 - 2014

N2 - Objectives Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique that has received increasing interest in the area of mood disorders over the last several years. While acute, double-blind, sham-controlled studies have already reported positive findings in terms of efficacy and safety for tDCS, follow-up data are lacking. This need prompted the present follow-up study, which assesses post-acute effects of tDCS (no maintenance stimulation was performed), in the mid-term, in a sample of major depressives. Methods After completing an acute, open trial of tDCS, 23 outpatients with either major depressive disorder or bipolar disorder entered a naturalistic follow-up (T1) with clinical evaluations at one week (T2), 1 month (T3), and 3 months (T4). A quantitative analysis of Hamilton Depression Rating Scale (HAM-D), Montgomery-Asberg Depression Rating Scale (MADRS), and Young Mania Rating Scale (YMRS) total scores, through repeated measures analysis of variance (ANOVA) (T1-T4) and paired t-test for comparing specific time points (T1-T2, T2-T3, and T3-T4), was performed. In addition, a qualitative analysis on the basis of treatment response and remission (HAM-D) was performed. Results Even though a progressive reduction of follow-up completers was observed from T2 to T4 (95.6% at T2, 65.2% at T3, and 47.8% at T4), the antidepressant effects of acute tDCS persisted over 3 months in almost half of the sample. Of note, no post-acute side effects emerged during the follow-up observation. The most frequent causes of drop-out from this study included major modifications in therapeutic regimen (30%) and poor adherence to follow-up visits (17%). Conclusions In this mid-term, open, follow-up study, tDCS showed mixed results. Further controlled studies are urgently needed to assess its effects beyond the acute phase.

AB - Objectives Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique that has received increasing interest in the area of mood disorders over the last several years. While acute, double-blind, sham-controlled studies have already reported positive findings in terms of efficacy and safety for tDCS, follow-up data are lacking. This need prompted the present follow-up study, which assesses post-acute effects of tDCS (no maintenance stimulation was performed), in the mid-term, in a sample of major depressives. Methods After completing an acute, open trial of tDCS, 23 outpatients with either major depressive disorder or bipolar disorder entered a naturalistic follow-up (T1) with clinical evaluations at one week (T2), 1 month (T3), and 3 months (T4). A quantitative analysis of Hamilton Depression Rating Scale (HAM-D), Montgomery-Asberg Depression Rating Scale (MADRS), and Young Mania Rating Scale (YMRS) total scores, through repeated measures analysis of variance (ANOVA) (T1-T4) and paired t-test for comparing specific time points (T1-T2, T2-T3, and T3-T4), was performed. In addition, a qualitative analysis on the basis of treatment response and remission (HAM-D) was performed. Results Even though a progressive reduction of follow-up completers was observed from T2 to T4 (95.6% at T2, 65.2% at T3, and 47.8% at T4), the antidepressant effects of acute tDCS persisted over 3 months in almost half of the sample. Of note, no post-acute side effects emerged during the follow-up observation. The most frequent causes of drop-out from this study included major modifications in therapeutic regimen (30%) and poor adherence to follow-up visits (17%). Conclusions In this mid-term, open, follow-up study, tDCS showed mixed results. Further controlled studies are urgently needed to assess its effects beyond the acute phase.

KW - Bipolar disorder

KW - follow-up observation

KW - major depressive disorder

KW - poor response

KW - transcranial direct current stimulation (tDCS)

UR - http://www.scopus.com/inward/record.url?scp=84906552529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906552529&partnerID=8YFLogxK

U2 - 10.1017/S1092852913000497

DO - 10.1017/S1092852913000497

M3 - Article

C2 - 23962405

AN - SCOPUS:84906552529

VL - 19

SP - 347

EP - 354

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 4

ER -